Page 4 - Marker Testing Market News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marker testing market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marker Testing Market Today - Breaking & Trending Today

Point of Care Diagnostics Market worth $50.6 billion by 2025 - Exclusive Report by MarketsandMarkets


Point of Care Diagnostics Market worth $50.6 billion by 2025 - Exclusive Report by MarketsandMarkets
report Point of Care/Rapid Diagnostics Market
by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to 2025 , published by MarketsandMarkets, the global Point Of Care Diagnostics Market size is estimated to be USD 29.5 billion in 2020 and projected to reach USD 50.6 billion by 2025, at a CAGR of 11.4%.
Browse in-depth TOC on
187 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185
The point of care diagnostics market includes major Tier I and II suppliers like the point-of-care diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Johnson & Johnson (US), Danah ....

United States , United Kingdom , South Korea , Kostenloser Wertpapierhandel , Asia Pacific , Aashish Mehra , Technology Immunoassay , Becton Dickinson , Quidel Corporation , Product Service Instrument , Research Insight , Enduser Lab , Device Market Research Reports Consulting , Danaher Corporation , Rapid Diagnostics Market , Infectious Disease , Home Care , Point Of Care Diagnostics Market , Rapid Diagnostics , Roche Diagnostics , Abbott Laboratories , Siemens Healthineers , Chembio Diagnostics , North America , Sample Pages , Quidel Diagnostics ,

Global Cardiac Marker Testing Market (2020 to 2025) - Emerging Markets to Offer High-Growth Opportunities for Players


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global cardiac marker testing market is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.9%.
The growth in the cardiac marker testing market is majorly driven by the growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent. ....

United States , South Korea , Laura Wood , Perkinelmer Inc , Company Evaluation Matrix , Guangzhou Wondfo Biotech Co Ltd , Contract Research Services , Office Hours Call , Laboratory Testing Facilities , Research Methodology , Tosoh Corporation , Company Profiles , E St Office Hours Call , Medience Corporation , Assay Development Services , Bio Rad Laboratories Inc , Abbott Laboratories , Organizations For Research On Cardiac Biomarkers , Danaher Corporation , Cardiac Marker Testing Market , Myocardial Infarction , Congestive Heart Failure , North America , Latin America , Middle East , Topics Covered ,

Cardiac Marker Testing Market worth $5.5 billion by 2025 - Exclusive Report by MarketsandMarkets™


The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent.
The cardiac marker testing market includes major Tier I and II suppliers like Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Danaher Corporation (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. ....

United States , Asia Pacific , Aashish Mehra , Technology Immunoassay , Devices Market Research Reports Consulting , Product Service Instrument , Roche Diagnostics Ltd , Research Insight , Enduser Lab , Danaher Corporation , Marker Testing Market , Myocardial Infarction , Congestive Heart Failure , Marker Testing , Roche Diagnostics , Abbott Laboratories , Siemens Healthineers , North America , Sample Pages , Adjacent Markets , Medical Devices Market Research Reports , Related Reports , Care Diagnostics Market , Infectious Disease , Home Care , Vitro Diagnostics Market ,